Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
11 results
  1. MedlinePlus Drug Information: Caplacizumab-yhdp Injection 
    https://medlineplus.gov/druginfo/meds/a619030.html
    Caplacizumab-yhdp injection is used to treat acquired thrombotic thrombocytopenic purpura (aTTP; a disorder in which the ... combination with plasma exchange therapy and immunosuppressant medications. Caplacizumab-yhdp is in a class of medications called ...
  2. LiverTox - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK547852
    ... Channel Blockers Canakinumab Candesartan Cangrelor Cannabidiol Capecitabine Capreomycin Caplacizumab Capmatinib Captopril Carbamazepine Carbapenems Carbinoxamine Carbonic Anhydrase Inhibitors ...
  3. Drugs and Lactation Database (LactMed®) - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK501922
    ... Calcitriol Calendula Canagliflozin Canakinumab Candesartan Cannabidiol Cannabis Capecitabine Caplacizumab Capmatinib Capreomycin Capsaicin Capsicum Captopril Caraway Carbachol Carbamazepine ...
  4. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 23-December-2019
    resource.nlm.nih.gov/101762423
    ... On February 6, 2019, the FDA approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in ...